Yi Larson - Sep 14, 2023 Form 3 Insider Report for RayzeBio, Inc. (RYZB)

Role
Director
Signature
/s/ Jeff Woodley, Attorney-in-fact
Stock symbol
RYZB
Transactions as of
Sep 14, 2023
Transactions value $
$0
Form type
3
Date filed
9/14/2023, 07:27 PM
Previous filing
Jun 21, 2023
Next filing
Feb 27, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RYZB Employee Stock Option (Right to Buy) Sep 14, 2023 Common Stock 59.4K $1.86 Direct F1
holding RYZB Employee Stock Option (Right to Buy) Sep 14, 2023 Common Stock 14.3K $3.24 Direct F2
holding RYZB Employee Stock Option (Right to Buy) Sep 14, 2023 Common Stock 40.8K $3.24 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is subject to an early exercise provision and is immediately exercisable. Vesting is monthly over a 36-month period starting May 1, 2021 in equal monthly amounts.
F2 The option is subject to an early exercise provision and is immediately exercisable. Vesting is monthly over a 36-month period starting October 29, 2021 in equal monthly amounts.
F3 The option is subject to an early exercise provision and is immediately exercisable. Vesting is monthly over a 36-month period starting January 1, 2023 in equal monthly amounts.

Remarks:

Exhibit 24 - Power of Attorney